期刊文献+

广西肝癌家族CYP3A5基因多态性的研究 被引量:2

A Study on Gene Polymorphism of Cyp3a5 in Guangxi Liver Cancer Family
下载PDF
导出
摘要 目的探讨CYP3A5基因多态性与广西肝癌遗传易感性的关系。方法在广西肝癌高发区选取18个肝癌高发家族成员178例(高发组)及与之相对应的18个无肿瘤家族成员178例(对照组)为研究对象,用流行病学问卷调查方法收集两组相关资料,同时现场采集空腹外周静脉血10 ml,用多聚酶链-限制性片段长度多态性技术(PCR-RFLP)检测CYP3A5基因型。结果高发组GG基因型比例低于对照组(P<0.01),GA+AA基因型比例高于对照组(P<0.05)。高发组A等位基因比例高于对照组(P<0.05)。结论 CYP3A5基因多态性与广西肝癌的遗传易感性密切相关。 Objective Objective To investigate the relationship between genetic polymorphism of CYP3A5 and genetic susceptibility of hepatocellular carcinoma( HCC) in Guangxi. Methods One hundred and seventy-eight cases were collected from 18 HCC area of the high HCC incidence in Guangxi as high-risk group,and another 178 cases from 18 families with non-tumor history as control group. The relevant data of two groups were obtained through the epidemiological questionnaires. Concurrently,10 ml fasting peripheral blood was collected. The genotype of CYP3A5 was analyzed by polymerase chain reaction-restriction fragment length polymorphism( PCR-RFLP). Results The genotype ratio of GG was lower but of GA + AA was higher in the high-risk group in contrast with those in the control group( P〈0. 05). There was statistical difference in the A allele ratio between high-risk group and control group( P〈0. 05). Conclusion The gene polymorphism of CYP3A5 is closely associated with genetic susceptibility of HCC in Guangxi.
出处 《广西医学》 CAS 2014年第9期1199-1201,共3页 Guangxi Medical Journal
基金 广西医药卫生科研课题(Z2011093) 广西崇左市科学研究与技术开发计划项目(2011001)
关键词 肝癌 CYP3A5 基因多态性 遗传易感性 广西 Liver cancer CYP3A5 Gene polymorphism Genetic susceptibility Guangxi
  • 相关文献

参考文献11

  • 1E1-Serag HB, Rudolph KL. Hepatocellular carcinoma: epi- demiology and molecular carcinogenesis [ J ]. Gastroenterol- ogy,2007,132(7) :2 557 -2 576.
  • 2陈钦艳,王学燕,方钟燎,方孔雄,黄坚.广西隆安县HBsAg与原发性肝癌家系调查研究[J].广西医学,2012,34(4):385-387. 被引量:1
  • 3Wojnwski L,Turner PC, Pedersen B, et al. Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in the Gambia, West Africa [ J ]. Pharmaco- genetics ,2004,14 (10) :691 - 700.
  • 4Poulsen HE, Loft S, Wassermann K. Cancer risk related to genetic polymorphisms in carcinogen metabolism and DNA repair[ J]. Pharmacol Toxicol, 1993, ( Suppl 1 ) :93 - 103.
  • 5Kuehl P, Zhang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphie CYP3A5 expression [ J ]. Nat Genet, 2001, 27(4) :383 -391.
  • 6Wrighton SA, Brian WR, Sari MA, et al. Studies on the ex- pression and metabolic capabilities of human liver cyto- chrome P450Ⅲ A5 ( HLp3 ) [ J ]. Mol Pharmacol, 1990,38 (2) :207 -213.
  • 7Dandara C, Ballo R, Parker MI. CYP3A5 genotypes and risk of oesophageal cancer in two South African populations [ J ]. Cancer Letters,2005,225 (2) :275 - 282.
  • 8李振华,孔垂泽,王立忠.前列腺癌发生风险与CYP3A5基因多态性的关系[J].中华实验外科杂志,2003,20(12):1098-1099. 被引量:9
  • 9Tucker AN, Tkaczuk KA, Lewis LM, et al. Polymorphisms in cytochrame P4503A5 ( CYP3A5 ) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients [ J ]. Cancer Lett,2005,217 (1) :61 -72.
  • 10Bethke L, Webb E, Sellick G, et al. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3AS, CYPllA1, CYP17A1, CYP19A1 and colorectal cancer risk [ J ]. BMC Cancer,2007, (7) : 123.

二级参考文献9

共引文献8

同被引文献25

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部